Overview
Franz Recker practices practicing medicine in Aarau, Switzerland.
Mr. Recker is highly rated in 1 condition, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, and Urothelial Cancer.
He is actively involved in clinical research, co-authoring 37 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Franz Recker
Is Franz Recker a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Franz Recker is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Franz Recker participate in research or clinical trials?
Yes. Franz Recker has published 37 articles and abstracts on conditions like Prostate Cancer. You can view a list of Franz Recker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Prostate CancerMr. Recker isAdvanced. Learn about Prostate Cancer.
- Experienced
- Familial Prostate CancerMr. Recker isExperienced. Learn about Familial Prostate Cancer.
- Urothelial CancerMr. Recker isExperienced. Learn about Urothelial Cancer.